Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Percentage of respondents |
|---|---|
| Able to get all of their IBD prescription medications in prior 12 months | 87.1% |
| Have taken advanced medications (biologic therapy, biosimilar, and targeted synthetic small molecule) for IBD in prior 12 months | 75.1% |
| Experienced adverse health outcomes when unable to get or delayed in getting IBD medications | 69.4% |
| Experienced problems accessing IBD prescription due to health insurance | 56.2% |
| Experienced effects on daily life (work, school, and daily activities) when unable to get or delayed in getting IBD medications | 48.7% |
| Have taken corticosteroids for IBD in prior 12 months | 33.3% |
| Experienced insurance approval delays of 1 month or longer for IBD medications | 16.8% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Sources
Release date
October 2024
More information
Region
United States
Survey time period
February to June 2023
Number of respondents
2,251 respondents
Special properties
IBD patients and their caregivers
Method of interview
Online survey
Citation formats
